CFTR modulator | Page 2 | European Cystic Fibrosis Society (ECFS)

Evaluating the Effectiveness of a Novel CF Medication for People Without Common Cystic Fibrosis-causing Genetic Mutations

A Review of Cystic Fibrosis Sinus and Nasal Disease response to CFTR Modulator Therapy

Examining the potential for drug interactions with Trikafta®/Kaftrio® in people with cystic fibrosis

Current Prices versus Minimum Costs of Production for CFTR Modulators

The effect of CFTR modulation with elexacaftor-tezacaftor-ivacaftor on the anxiety sweat rate in people with cystic fibrosis

A serious consideration about the wise use of the new, highly efficient, very expensive, treatment for cystic fibrosis (Trikafta©/Kaftrio©)

Worldwide Estimates of Cystic Fibrosis Diagnosis and Treatment Access

The effect of ETI (Trikafta™) on blood sugars in adults with cystic fibrosis

New perspectives on physical exercise training in adults and children with cystic fibrosis

Orkambi may improve liver disease in people with CF